Knockdown of DIAPH3 Inhibits the Proliferation of Cervical Cancer Cells through Inactivating mTOR Signaling Pathway

Table 3

Expression of DIAPH3 in cervical cancer according to patients’ clinicopathological characteristics.

Characteristics	Number	DIAPH3 expression		value
		High-risk group	Low-risk group
Age (years)
<50	19	11	8	0.352
≥50	23	10	13
Differentiation
Well/moderate	26	12	14	0.525
Poor	16	9	7
Size (cm)
<3	24	8	16	0.013
≥3	18	13	5
FIGO stage
I	24	9	15	0.061
II and III	18	12	6
Lymph node metastasis
No	25	13	12	0.753
Yes	17	8	9

statistically significant difference.